Catalyst overview
Research summary
This catalyst tracks a Phase 1b data readout for DISC-3405 (Hepcidin Induction) in Sickle Cell Disease. The expected timing is based on the latest available company guidance and may change.
07/30/26:- Phase 1b SCD study progressing; initial data expected Q4 2026.
Verification
Confirm timing and program details against the company announcement or filing.